{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:39:24Z","timestamp":1792802364267,"version":"4.5.0"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100018693","name":"HORIZON EUROPE","doi-asserted-by":"crossref","award":["101103089"],"award-info":[{"award-number":["101103089"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Medicine donation programs have been central to neglected tropical disease (NTD) control, particularly for soil-transmitted helminths (STH), but growing concerns about sustainability, supply continuity, and country ownership highlight the need for new access models. A novel fixed-dose combination (FDC) of ivermectin and albendazole, recently endorsed by the European Medicines Agency, offers programmatic advantages over monotherapy. Unlike some existing treatments, the FDC may not be donated. This paper examines how the current drug donation landscape for STH shapes the prospects for future supply and financing of the FDC.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Evidence for this paper was synthesized from a structured review of peer-reviewed and gray literature, supplemented by expert consultation. Data drawn from WHO\u2019s Service Availability and Readiness Assessment (SARA) database on essential medicine availability, estimates of public health spending, and the World Bank\u2019s World Development Indicators on health expenditure support the qualitative reports from sampled sources. Findings were interpreted within a framework examining three interrelated determinants of sustainable access: facility-level availability of essential medicines, health financing patterns, and existing donation models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The analysis involved the review of 35 sources on essential medicine availability, financing, and supply of critical medical products, and medicine donation. SARA data showed striking gaps in essential medicine availability in health facilities, with some low- and lower-middle-income countries (LICs, LMICS) reporting zero facilities with sustainable availability. On health financing, African and Asian countries are spending only about half of what is called for in targets. Low- and lower-middle income countries remain heavily dependent on external aid and out-of-pocket spending, in stark contrast to high- and upper-middle and high-income countries where domestic public financing predominates. Further, no pooled or coordinated global financing mechanism currently exists for NTD medicines, leaving supply fragmented and reliant on donations. Existing donation programs for albendazole, mebendazole, and ivermectin have achieved wide-scale coverage and impact but have not fostered sustainable domestic procurement or integration into primary health care systems.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Introduction of the FDC in the absence of donation schemes poses significant financing and supply challenges, especially for LICs and LMICs where essential medicine availability is already limited. However, it also presents an opportunity to reset NTD access models by embedding sustainable financing strategies, such as pooled procurement, tiered pricing, and primary health care integration, from the outset. Early planning with manufacturers, donors, and governments will be essential to ensure equitable access and country ownership of this novel treatment.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pntd.0014458","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:37:31Z","timestamp":1783618651000},"page":"e0014458","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":1,"title":["Implications of global health funding patterns for implementation of a novel soil-transmitted helminth and lymphatic filariasis medicine: Ivermectin\/albendazole fixed-dose combination"],"prefix":"10.1371","volume":"20","author":[{"given":"Israel","family":"Wuresah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4666-1934","authenticated-orcid":true,"given":"Alan","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikita","family":"Kubal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Krolewiecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"issue":"2","key":"pntd.0014458.ref001","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1093\/trstmh\/traa167","article-title":"Medicine donation programmes supporting the global drive to end the burden of neglected tropical diseases","volume":"115","author":"M Bradley","year":"2021","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0014458.ref002","doi-asserted-by":"crossref","DOI":"10.1093\/trstmh\/traa196","article-title":"Considerations for a sustainability framework for neglected tropical diseases programming","volume":"115","author":"M Espinal","year":"2021","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0014458.ref003","doi-asserted-by":"crossref","DOI":"10.1093\/inthealth\/ihaa077","article-title":"The role of medicine donations in the global programme for the elimination of lymphatic filariasis","volume":"13","author":"T Williams","year":"2020","journal-title":"Int Health"},{"issue":"16","key":"pntd.0014458.ref004","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1001\/jama.298.16.1911","article-title":"Oral drug therapy for multiple neglected tropical diseases: a systematic review","volume":"298","author":"M Reddy","year":"2007","journal-title":"JAMA"},{"key":"pntd.0014458.ref005","doi-asserted-by":"crossref","first-page":"106943","DOI":"10.1016\/j.ijid.2024.01.010","article-title":"Control, elimination, and eradication efforts for neglected tropical diseases in the World Health Organization African region over the last 30 years: a scoping review","volume":"141","author":"CM Wolfe","year":"2024","journal-title":"Int J Infect Dis"},{"issue":"10","key":"pntd.0014458.ref006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012521","article-title":"Need for a paradigm shift in soil-transmitted helminthiasis control: targeting the right people, in the right place, and with the right drug(s)","volume":"18","author":"PM Emerson","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0014458.ref007","author":"Uniting Combat NTDs."},{"key":"pntd.0014458.ref008","author":"Expanded Special Project for Elimination of Neglected Tropical Diseases"},{"key":"pntd.0014458.ref009","author":"History of the Program"},{"key":"pntd.0014458.ref010","author":"World Health Organization","year":"2020"},{"key":"pntd.0014458.ref011","author":"eEML - Electronic Essential Medicines List"},{"key":"pntd.0014458.ref012","author":"World Health Organization","year":"2024"},{"key":"pntd.0014458.ref013","author":"World Bank","year":"2024"},{"issue":"11","key":"pntd.0014458.ref014","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(22)00369-3","article-title":"Ivermectin and albendazole coadministration: opportunities for strongyloidiasis control","volume":"22","author":"J Gandasegui","year":"2022","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"pntd.0014458.ref015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012211","article-title":"Sustaining the gains achieved by national neglected tropical disease (NTD) programs: how can we build NTD program country ownership and sustainability?","volume":"18","author":"Y Sodahlon","year":"2024","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0014458.ref016","author":"World Health Organization","year":"2021"},{"issue":"12","key":"pntd.0014458.ref017","article-title":"Sustainable access to deworming drugs in a changing landscape","volume":"18","author":"WM Lin","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"pntd.0014458.ref018","unstructured":"Global Institute for Disease Elimination. Innovative financing for neglected tropical diseases discussion paper. 2023."},{"issue":"9","key":"pntd.0014458.ref019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0013059","article-title":"Fixed-dose ivermectin for Mass Drug Administration: is it time to leave the dose pole behind? Insights from an individual participant data meta-analysis","volume":"19","author":"A Echazu","year":"2025","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0014458.ref020","article-title":"A Phase II\/III trial of an albendazole-ivermectin coformulation for the treatment of Trichuris trichiura and other soil-transmitted helminths","author":"A Krolewiecki","year":"2023","journal-title":"Lancet Infect Dis"},{"key":"pntd.0014458.ref021","article-title":"Fixed-dose ivermectin for mass drug administration: is it time to leave the dose pole behind? Insights from an individual participant data meta-analysis","author":"A Echazu","year":"2025","journal-title":"medRxiv"},{"issue":"5","key":"pntd.0014458.ref022","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S1473-3099(24)00669-8","article-title":"Albendazole-ivermectin co-formulation for the treatment of Trichuris trichiura and other soil-transmitted helminths: a randomised phase 2\/3 trial","volume":"25","author":"A Krolewiecki","year":"2025","journal-title":"Lancet Infect Dis"},{"key":"pntd.0014458.ref023","author":"European Medicines Agency","year":"2025"},{"key":"pntd.0014458.ref024","author":"WHO","year":"2025"},{"key":"pntd.0014458.ref025","author":"WHO","year":"2024"},{"key":"pntd.0014458.ref026","author":"PAHO WHO","year":"2018"},{"issue":"1","key":"pntd.0014458.ref027","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006153","article-title":"Geographical distribution of soil transmitted helminths and the effects of community type in South Asia and South East Asia - a systematic review","volume":"12","author":"ZA Silver","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0014458.ref028","author":"B Gilmour","year":"2025","journal-title":"Mapping the prevalence of soil-transmitted helminth infections in the Western Pacific Region: a spatial modelling study. In: Lancet Reg Health \u2013 West Pac [Internet]. Elsevier"},{"key":"pntd.0014458.ref029","author":"World Bank"},{"key":"pntd.0014458.ref030","author":"Human Rights Watch","year":"2024"},{"key":"pntd.0014458.ref031","author":"World Bank DHD"},{"issue":"11","key":"pntd.0014458.ref032","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2025-021270","article-title":"Avoidable pitfalls on the path to health financing self-reliance in low-income and middle-income countries","volume":"10","author":"E Barasa","year":"2025","journal-title":"BMJ Glob Health"},{"key":"pntd.0014458.ref033","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2022.11.037","article-title":"Sustainable financing for immunization agenda 2030","volume":"42","author":"H Saxenian","year":"2024","journal-title":"Vaccine"},{"key":"pntd.0014458.ref034","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(24)01439-9","article-title":"Global health 2050: the path to halving premature death by mid-century","volume":"404","author":"DT Jamison","year":"2024","journal-title":"Lancet Lond Engl"},{"key":"pntd.0014458.ref035"},{"key":"pntd.0014458.ref036","article-title":"The Pan American Health Organization\u2019s Revolving Fund for access to vaccines: 43 years responding to the regional immunization programO Fundo Rotativo para Acesso a Vacinas da Organiza\u00e7\u00e3o Pan-Americana da Sa\u00fade: 43 anos respondendo ao Programa Regional de Imuniza\u00e7\u00f5es","volume":"47","author":"S Cornejo","year":"2023","journal-title":"Pan Am J Public Health"},{"key":"pntd.0014458.ref037","author":"Mectizan Donation Program"},{"key":"pntd.0014458.ref038","author":"IFPMA","year":"2025"},{"key":"pntd.0014458.ref039","author":"Merck","year":"2022"},{"key":"pntd.0014458.ref040","author":"Mectizan Donation Program","year":"2025"},{"key":"pntd.0014458.ref041"},{"key":"pntd.0014458.ref042","author":"Mectizan Donation Program, The Task Force for Global Health"},{"issue":"1","key":"pntd.0014458.ref043","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12992-023-00974-1","article-title":"Does structural form matter? A comparative analysis of pooled procurement mechanisms for health commodities","volume":"19","author":"K Parmaksiz","year":"2023","journal-title":"Global Health"},{"key":"pntd.0014458.ref044","doi-asserted-by":"crossref","first-page":"102996","DOI":"10.1016\/j.jhealeco.2025.102996","article-title":"Procurement institutions and essential drug supply in low and middle-income countries","volume":"101","author":"LX Wang","year":"2025","journal-title":"J Health Econ"},{"key":"pntd.0014458.ref045","first-page":"1","article-title":"Implementation of Medicines Pricing Policies in Ghana: The Interplay of Policy Content, Actors\u2019 Participation, and Context. Int J Health Policy Manag. Kerman University of Medical Sciences;","volume":"12","author":"A Koduah","year":"2023"},{"key":"pntd.0014458.ref046","author":"M Van Beusekom","year":"2025"},{"key":"pntd.0014458.ref047","author":"World Bank","year":"2022"},{"key":"pntd.0014458.ref048","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2147\/CEOR.S413546","article-title":"Challenges to the availability and affordability of essential medicines in African countries: a scoping review","volume":"15","author":"A Yenet","year":"2023","journal-title":"Clinicoecon Outcomes Res"},{"key":"pntd.0014458.ref049","author":"WHO","year":"2023"},{"issue":"8","key":"pntd.0014458.ref050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009625","article-title":"Modelling the ability of mass drug administration to interrupt soil-transmitted helminth transmission: community-based deworming in Kenya as a case study","volume":"15","author":"NS Chong","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"pntd.0014458.ref051","doi-asserted-by":"crossref","DOI":"10.1186\/s13071-021-04620-w","article-title":"Deworming women of reproductive age during adolescence and pregnancy: what is the impact on morbidity from soil-transmitted helminths infection?","volume":"14","author":"C Vegvari","year":"2021","journal-title":"Parasit Vectors"},{"key":"pntd.0014458.ref052","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4269\/ajtmh.22-0767","article-title":"Mass drug administration: contextual factor considerations","volume":"110","author":"ZD Schneider","year":"2024","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"pntd.0014458.ref053","doi-asserted-by":"crossref","first-page":"258","DOI":"10.9745\/GHSP-D-18-00425","article-title":"The challenges of transition from donor-funded programs: results from a theory-driven multi-country comparative case study of programs in Eastern Europe and Central Asia supported by the global fund","volume":"7","author":"G Gotsadze","year":"2019","journal-title":"Glob Health Sci Pract"},{"issue":"1","key":"pntd.0014458.ref054","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s40249-018-0447-y","article-title":"Capacity gaps in health facilities for case management of intestinal schistosomiasis and soil-transmitted helminthiasis in Burundi","volume":"7","author":"P Bizimana","year":"2018","journal-title":"Infect Dis Poverty"},{"key":"pntd.0014458.ref055","first-page":"225","article-title":"State-wide situation analysis of availability of basic resuscitation devices and essential drugs in primary and secondary healthcare facilities in Cross River State, Nigeria","volume":"42","author":"QN Kalu","year":"2022","journal-title":"Pan Afr Med J"},{"key":"pntd.0014458.ref056","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087576","article-title":"Essential medicines are more available than other medicines around the globe","volume":"9","author":"YT Bazargani","year":"2014","journal-title":"PLoS One"},{"issue":"4","key":"pntd.0014458.ref057","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1136\/thorax-2024-222391","article-title":"Availability, cost and affordability of essential medicines for smoking cessation in low-income and middle-income countries: a cross-sectional study","volume":"80","author":"C Plum","year":"2025","journal-title":"Thorax"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0014458","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:37:36Z","timestamp":1783618656000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0014458"}},"subtitle":[],"editor":[{"given":"Benjamin L.","family":"Makepeace","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":57,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7,9]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0014458","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]}}}